Literature DB >> 4266903

Topical drug addiction: adverse effects of fluorinated corticosteroid creams and ointments.

J N Burry.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4266903     DOI: 10.5694/j.1326-5377.1973.tb118065.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

1.  Letter: Fluorinated corticosteroids and dermatophytosis.

Authors:  J N Burry
Journal:  Br Med J       Date:  1975-07-05

2.  Oral Administration of Melatonin or Succinyl Melatonin Niosome Gel Benefits 5-FU-Induced Small Intestinal Mucositis Treatment in Mice.

Authors:  Prangtip Uthaiwat; Aroonsri Priprem; Sirinart Chio-Srichan; Chatri Settasatian; Yao-Chang Lee; Pramote Mahakunakorn; Patcharee Boonsiri; Chanvit Leelayuwat; Patcharaporn Tippayawat; Ploenthip Puthongking; Jureerut Daduang
Journal:  AAPS PharmSciTech       Date:  2021-07-01       Impact factor: 3.246

Review 3.  Topical steroid addiction in atopic dermatitis.

Authors:  Mototsugu Fukaya; Kenji Sato; Mitsuko Sato; Hajime Kimata; Shigeki Fujisawa; Haruhiko Dozono; Jun Yoshizawa; Satoko Minaguchi
Journal:  Drug Healthc Patient Saf       Date:  2014-10-14

4.  Topical corticosteroid misuse: the Indian scenario.

Authors:  Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

5.  Topical corticosteroid addiction and phobia.

Authors:  Aparajita Ghosh; Sujata Sengupta; Arijit Coondoo; Amlan Kusum Jana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

6.  Topical Steroid Damaged/Dependent Face (TSDF): An Entity of Cutaneous Pharmacodependence.

Authors:  Koushik Lahiri; Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

7.  Effect of Topical Steroid-Dependent Facial Dermatitis on Quality of Life: A Hospital-Based Cross-Sectional Study Using DLQI.

Authors:  Madhur K Rastogi; Rikta Mohan; Pratik Gahalaut; Nitin Mishra; Manisha Thapa
Journal:  Indian J Dermatol       Date:  2019 Nov-Dec       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.